步长制药：2025年半年度归属于上市公司股东的净利润同比增长171.24%

Group 1 - The company reported a revenue of 5,663,836,253.89 yuan for the first half of 2025, representing a year-on-year growth of 4.27% [1] - The net profit attributable to shareholders of the listed company was 627,701,257.33 yuan, showing a significant year-on-year increase of 171.24% [1]